Cough syrup tragedy: a medicine turned into a poison

General
,
1

Thank you for the feedback

Sorry, I couldn’t find a similar post in the search.

Can you help me solve this issue?

Cough syrup tragedy: a medicine turned into a poison

Recently, heartbreaking news about the death of innocent kids due to the consumption of contaminated cough syrup was reported. At least 16 children lost their lives in the tragedy, which exposes the serious violation of drug safety and regulation.

The cause of death is the presence of Diethylene glycol (DEG), a toxic industrial chemical commonly used in antifreeze, brake fluids, and plastic manufacturing. Diethylene glycol is used as a solvent in cough syrup, and the permissible dose in a pharmaceutical product is 0.1%. The contaminated batch was found to have an alarming 48.6%, which is 500 times the allowable limit.

Diethylene glycol is metabolised in the liver, and the toxic byproduct can lead to kidney failure, impairment in the nervous system, and death. A safe alternative, such as propylene glycol, should be used instead of diethylene glycol. To reduce production costs and increase profits, some pharmaceutical companies resort to using unsafe chemicals.

Sadly, this is not the first incident. Similar issues have been reported previously in 1998, 2020, and 2022. Still, regulatory authorities have not taken strict action against such pharmaceutical companies.

This raises the question

Are the drug safety rules strong enough to protect our lives?

We need good regulatory rules at the global and national levels. Drug regulations and policies should prioritise the value of human life above anything.

What are your thoughts about the regulations and policies in the pharmaceutical industry? What changes should be made?

MBH/AB

4 Likes
2

Stricter transparency and faster approval for lifesaving drugs are key, patients shouldn’t wait years for innovation.

1 Like
3

Pharmaceutical regulations need to be far stricter, with rigorous quality checks and transparent accountability at every production stage. Stronger global oversight and harsher penalties for violations are essential to ensure that profit never outweighs patient safety.

1 Like
4

This tragedy exposes serious oversight gaps in pharmaceuticals, which is truly heartbreaking :pensive_face:. To stop such occurrences, stronger international and domestic laws, more stringent quality assurance, and open accountability are necessary. Patient safety should always come before profit. Better international coordination, more severe sanctions for infractions, and routine audits could have a significant impact. Do you believe that the best way to stop these kinds of cases would be through stronger enforcement or improved manufacturing standards?

1 Like
6

I think it should be both.